Detalles de la búsqueda
1.
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.
Blood
; 118(16): 4353-8, 2011 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21846902
2.
Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors.
Am J Hematol
; 88(12): 1024-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23913852
3.
Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.
Blood
; 116(6): 886-92, 2010 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20427701
4.
Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.
Blood
; 114(11): 2232-5, 2009 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19531657
5.
Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemia.
Am J Hematol
; 84(4): 256-7, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19260121
6.
Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib.
Cancer
; 117(5): 982-91, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20960502
7.
Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia.
Cancer
; 117(10): 2145-55, 2011 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21523727
8.
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy.
Cancer
; 116(11): 2673-81, 2010 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20499401
9.
Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.
Leuk Lymphoma
; 51(5): 778-82, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20196624
10.
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.
Cancer
; 115(1): 101-6, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19090005
11.
Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha.
Leuk Lymphoma
; 49(7): 1399-402, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18452066
Resultados
1 -
11
de 11
1
Próxima >
>>